Haemonetics Corporation (HAE) Financials

HAE Assets vs Liabilities
DateAssetsLiabilities
March 28, 2026 2.4 billion 1.6 billion
Dec. 31, 2025 2.5 billion 1.6 billion
Sept. 30, 2025 2.4 billion 1.6 billion
June 30, 2025 2.5 billion 1.6 billion

HAE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 28, 2026 53.3 million ?
Dec. 31, 2025 87.2 million 7.8 million
Sept. 30, 2025 106.3 million 7.6 million
June 30, 2025 13.6 million 9.3 million

HAE Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 28, 2026 -20.1 million
Dec. 31, 2025 44.7 million
Sept. 30, 2025 38.7 million
June 30, 2025 34.0 million

HAE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 28, 2026 245.4 million 1.2 billion -
Dec. 31, 2025 363.4 million 920.0 million -
Sept. 30, 2025 296.4 million 920.4 million -
June 30, 2025 292.9 million 920.8 million -

HAE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 28, 2026 ?
Dec. 31, 2025 47.0 million
Sept. 30, 2025 47.7 million
June 30, 2025 48.4 million

HAE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 28, 2026 17.7 million 14.4 million 121.8 million -
Dec. 31, 2025 6.3 million 14.3 million 107.6 million -
Sept. 30, 2025 5.0 million 14.5 million 101.6 million -
June 30, 2025 3.8 million 16.3 million 110.7 million -

HAE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 28, 2026 346.4 million 148.1 million
Dec. 31, 2025 339.0 million 147.6 million
Sept. 30, 2025 327.3 million 143.9 million
June 30, 2025 321.4 million 129.5 million

HAE Revenue by Segment
Graph available only for paid members. Upgrade to see it.

HAE

Price: $77.29

52 week price:
47.32
87.32

Earnings Per Share: 3.63 USD

P/E Ratio: 15.71

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 121503

Ebitda: 23.3 million

Market Capitalization: 3.4 billion

Links: